Advent International to invest ₹2,475 crore in Apollo Hospitals arm
Summary
This investment, amounting to nearly $297 million, marks a strategic manoeuvre by Advent, enabling a merger between Apollo HealthCo’s online pharmacy arm, Apollo 24/7, and pharmaceutical distributor Keimed.
Private equity firm Advent International has revealed its plans to inject ₹2,475 crore into Apollo Hospitals’ subsidiary, Apollo HealthCo. This investment, amounting to nearly $297 million, marks a strategic manoeuvre by Advent, enabling a merger between Apollo HealthCo’s online pharmacy arm, Apollo 24/7, and pharmaceutical distributor Keimed.
The announcement, made on Friday, April 26, outlines Advent’s investment strategy, structured in two tranches of compulsory convertible instruments. These investments aim to secure Advent a 12.1% ownership stake in the merged entity, placing its valuation at an enterprise value of ₹22,481 crore.
Breaking down the valuation further, Apollo HealthCo commands a valuation of ₹4,478 crore, while Keimed holds a value of ₹8,003 crore, according to statements from the hospital chain operator.
Projections for the merged entity paint a promising picture, with an anticipated revenue surge expected to reach ₹25,000 crore over the next three years, as disclosed by Suneeta Reddy, Managing Director of Apollo Hospitals.
Under the newly-formed alliance, Apollo Hospitals is poised to maintain the majority of control, with a commanding 59.2% stake in the merged entity. Meanwhile, Keimed will secure a significant 25.7% ownership interest.
This investment reflects a broader trend of increasing private equity interest in India’s healthcare sector. Private equity firms are increasingly recognising the immense potential within the Indian healthcare landscape, as evidenced by a record-breaking surge of over $4 billion in investments in 2023.
In the tide of healthcare investments, private equity players like Temasek and Blackstone have emerged as titans, reshaping the sector’s landscape.
Temasek’s landmark acquisition of a 41% stake in Bengaluru’s Manipal Hospitals for a staggering $2 billion highlights the scale of transformation underway.
Meanwhile, Blackstone’s foray into the Indian healthcare domain with a $1 billion investment in CARE Hospitals further cements the sector’s allure for global investors.
The table below highlights key PE investments in Indian healthcare:
PE Firm | Target Hospital/Company | Investment Amount | Stake Acquired |
Temasek | Manipal Hospitals | $2 billion | 41% |
Blackstone | CARE Hospitals | $1 billion | Majority |
True North | Kerala’s KIMS | Undisclosed | Majority |
Others | Kauvery Hospitals, IVY Health, India IVF, Asian Institute of Nephrology & Urology | Varied | Varied |
Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout
3 Mins Read
Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter